Recent marijuana use in HIV-infected Russians associated with increased sex and drug risk behaviors

February 13, 2013 in HIV & AIDS

Researchers from Boston Medical Center (BMC) and Boston University's School of Medicine (BUSM) and School of Public Health (BUSPH) have found that in Russian HIV-infected risky drinkers, marijuana use is associated with other increased risky behaviors involving drug use and sex. These findings, published online in the journal Drug and Alcohol Dependence, may aid clinicians and public health experts in detecting individuals at a higher risk of transmitting HIV.

, otherwise known as cannabis, is the most frequently used worldwide. Previous research has shown that in certain non-HIV infected populations, marijuana use is associated with the use of other drugs such as cocaine and heroin, as well as an increase in and a larger number of sexual partners. In Russia, the has been largely propelled by injection drug use (IDU), although through unprotected sex is increasing. Still, not much is known about marijuana use and its impact on those behaviors in individuals already infected with HIV.

To investigate this, Jeffrey Samet, MD, MPH, from the Clinical Addiction Research and Education (CARE) Unit at BUSM and colleagues examined data collected in St. Petersburg, Russia, in a cohort of 700 HIV-infected individuals with risky drinking practices. Risky drinkers were defined as men who drink more than four drinks a day or 14 drinks a week and women who consume more than three drinks a day or seven drinks a week. In this population, the frequency of marijuana use within the previous year was determined and those who used were compared to the non-users with regard to risky drug and , including needle sharing, IDU, the number of sex partners and frequency of condom use.

Working with colleagues from Russia, the researchers found that baseline marijuana use was relatively common, with 20 percent having used within the previous month and 46 percent within the previous year. Forty-two percent of the respondents admitted to IDU and 23 percent to sharing needles within the previous 30 days, and 27 percent reported multiple sexual partners in the previous three months.

The data also showed a significant association among individuals who reported using marijuana within the previous 30 days and an increase in sharing needles, IDU and increase in the number of injections. In addition, while marijuana use was not associated with decreased , it was associated with an increased number of sexual partners.

The study results indicate that asking HIV-infected patients about marijuana use may identify those who are at a higher risk for transmitting HIV.

"I don't think physicians currently inquire about marijuana use among HIV-infected individuals in part because they are not sure what to do with the information," said Samet, chief of general internal medicine at BMC and the article's corresponding author. "Given these findings and the high prevalence of marijuana use, it is important to explore whether or not its use results in risky behavior."

Journal reference: Drug and Alcohol Dependence search and more info website

Provided by Boston University Medical Center search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Integrating mental health care into HIV care

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

HIV & AIDS created 12 hours ago | popularity not rated yet | comments 0

After a decade, global AIDS program looks ahead

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

HIV & AIDS created May 21, 2013 | popularity not rated yet | comments 0

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created May 18, 2013 | popularity 5 / 5 (2) | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0


Study says empathy plays a key role in moral judgments

Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...

Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.